Results for Fanconi Anemia

1 - 7 of 7
Peter Kurre, MD
Peter Kurre

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

E-mail:
kurrep [at] chop.edu
Wei Tong, PhD
Wei Tong

Dr. Tong investigates cytokine receptor signaling in normal and neoplastic hematopoietic development. She uses integrated approaches encompassing biochemistry, molecular biology, mouse models, and primary human samples to understand signaling events emanating from cytokine receptors that regulate the development of hematopoietic stem/progenitor cells.

E-mail:
tongw [at] chop.edu

CHOP Physician-Scientist in Search of Cure for Fanconi Anemia

Published on
Oct 15, 2020
in Cornerstone Blog
CHOP Physician-Scientist in Search of Cure for Fanconi Anemia
Peter Kurre, MD, seeks to determine to what extent defects in fetal blood forming cells accelerate the loss of bone marrow function in young patients.

Targeting Abnormal Signals Suggests Novel Method to Treat a Rare Childhood Blood Disease

Published on
Oct 9, 2018
in Press Releases
In Animal Study, CHOP Hematologist Restores Blood Cell Function in Fanconi Anemia

Kurre Laboratory

Kurre Laboratory

The Kurre Laboratory has a longstanding interest in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications.

Kurre Lab Research Overview

The Kurre Laboratory has a longstanding interest in Fanconi anemia (FA), a rare inherited genetic condition with prominent hematologic complications.

Comprehensive Bone Marrow Failure Center

Comprehensive Bone Marrow Failure Center

The Comprehensive Bone Marrow Failure Center brings together physicians and researchers to provide state-of-the-art diagnostics, clinical care, and investigational studies, as well as basic research focused on acquired and inherited bone marrow failure.

1 - 7 of 7